drugset / Trial / NCT03977792

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

NCT03977792

Phase 2 Unknown 164 enrolled Laboratoire Boreaderme Inc. Ecogene 21 · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

BOR15001L7 is a natural product. The primary objective of this study is to demonstrate its non-inferiority to docosanol 10% based on the healing time of cold sores in patients with recurrent herpes labialis.

Timeline

Start
2020-09
Primary completion
2021-07
Completion
2022-07

Drugs

EvaluationDrugModalityDoseRoute
Subject BOR15001L7 Other / unclassified Topical
Comparator Docosanol Small molecule 10 % Topical

Indications